Replimune (REPL) Enterprise Value (2018 - 2025)
Replimune has reported Enterprise Value over the past 8 years, most recently at -$269.1 million for Q4 2025.
- Quarterly results put Enterprise Value at -$269.1 million for Q4 2025, up 49.84% from a year ago — trailing twelve months through Dec 2025 was -$269.1 million (up 49.84% YoY), and the annual figure for FY2025 was -$483.8 million, down 15.01%.
- Enterprise Value reached -$269.1 million in Q4 2025 per REPL's latest filing, up from -$323.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$269.1 million in Q4 2025 and bottomed at -$616.4 million in Q4 2022.
- Median Enterprise Value over the past 5 years was -$447.1 million (2021), compared with a mean of -$446.9 million.
- The largest annual shift saw Enterprise Value plummeted 226.76% in 2021 before it soared 49.84% in 2025.
- Over 5 years, Enterprise Value stood at -$420.2 million in 2021, then crashed by 46.7% to -$616.4 million in 2022, then rose by 24.34% to -$466.4 million in 2023, then fell by 15.05% to -$536.5 million in 2024, then skyrocketed by 49.84% to -$269.1 million in 2025.
- Business Quant data shows Enterprise Value for REPL at -$269.1 million in Q4 2025, -$323.6 million in Q3 2025, and -$403.3 million in Q2 2025.